John White, MD
Obstetrics & Gynecology · Daytona Beach, FLNPI 1053422709
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,400 of the $8,190 with a category attached, or 78.1%. Mimedx Group, Inc. accounts for 78.1% of it on its own, with 28 other manufacturers making up the rest. 2024 is the largest year on record at $6,492, more than ten times the $594 reported in 2019. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $78.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$6K
- AbbVie$462
- Pfizer$171
- Duchesnay USA Incorporated$152
- Exeltis, USA Inc.$126
- Millicent US Inc$117
- plus $762 from 23 others
Across 5 payments — averaging $5685.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$23K
- Sanofi Pasteur Inc.$5K
What the payments were for
- Consulting fees$6,40078%
- Food & beverage$1,74321%
- Education$461%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 9 | $6,400 |
| AbbVie(2 entities) | 23 | $462 |
| Pfizer | 10 | $171 |
| Duchesnay USA Incorporated | 7 | $152 |
| Exeltis, USA Inc. | 7 | $126 |
| Millicent US Inc | 6 | $117 |
| Therapeuticsmd, Inc. | 4 | $74 |
| Medtronic | 1 | $66 |
| Avion Pharmaceuticals | 4 | $57 |
| Amgen | 3 | $53 |
| Mayne Pharma Commercial LLC | 3 | $51 |
| Myovant Sciences Inc. | 3 | $49 |
| Ascend Therapeutics US, LLC | 4 | $49 |
| Smith+Nephew | 2 | $38 |
| Johnson & Johnson | 2 | $38 |
| Evofem Biosciences, Inc. | 2 | $37 |
| Medicem Inc. | 1 | $26 |
| Hologic Sales And Service, LLC | 2 | $24 |
| LSI Solutions Inc | 1 | $22 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $18 |
| Bayer | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Bolder Surgical LLC | 1 | $15 |
| Davol Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Osphena$122
How this compares
$8,190 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 41 | $15,538 |
| Estradiol | 321 | $11,518 |
| MyrbetriqMirabegron | 12 | $5,296 |
| Raloxifene Hcl | 78 | $4,722 |
| Estradiol (Once Weekly)Estradiol | 33 | $2,971 |
| Estradiol (Twice Weekly)Estradiol | 35 | $2,697 |
| ValacyclovirValacyclovir Hcl | 57 | $1,832 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 14 | $1,389 |
| Clobetasol Propionate | 45 | $1,074 |
| ProgesteroneProgesterone, Micronized | 38 | $1,044 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 64 | $732 |
| Metronidazole | 11 | $426 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $420 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 33 | $389 |
| Acyclovir | 24 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $171 | $15,53841 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Daytona Beach
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.